Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir–ritonavir in patients hospitalised with COVID-19: a target trial emulation study

{ 'indexed': {'date-parts': [[2024, 7, 16]], 'date-time': '2024-07-16T00:22:31Z', 'timestamp': 1721089351019}, 'reference-count': 33, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/legal/tdmrep-license'}, { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-017'}, { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-037'}, { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-012'}, { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-029'}, { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-004'}], 'funder': [{'DOI': '10.13039/501100005847', 'name': 'HMRF', 'doi-asserted-by': 'publisher'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.com', 'em-consulte.com', 'thelancet.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2024, 7]]}, 'DOI': '10.1016/s1473-3099(24)00353-0', 'type': 'journal-article', 'created': {'date-parts': [[2024, 7, 15]], 'date-time': '2024-07-15T22:32:52Z', 'timestamp': 1721082772000}, 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 1, 'title': 'Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir ' 'versus monotherapy with remdesivir or nirmatrelvir–ritonavir in patients hospitalised with ' 'COVID-19: a target trial emulation study', 'prefix': '10.1016', 'author': [ {'given': 'Ming Hong', 'family': 'Choi', 'sequence': 'first', 'affiliation': []}, {'given': 'Eric Yuk Fai', 'family': 'Wan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ian Chi Kei', 'family': 'Wong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Esther Wai Yin', 'family': 'Chan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wing Ming', 'family': 'Chu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anthony Raymond', 'family': 'Tam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kwok Yung', 'family': 'Yuen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ivan Fan Ngai', 'family': 'Hung', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/S1473-3099(24)00353-0_bib2', 'series-title': 'Interim recommendation on clinical management of adult cases with ' 'coronavirus disease 2019 (COVID-19)', 'year': '2022'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib3', 'doi-asserted-by': 'crossref', 'first-page': '1813', 'DOI': '10.1056/NEJMoa2007764', 'article-title': 'Remdesivir for the treatment of COVID-19—final report', 'volume': '383', 'author': 'Beigel', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib4', 'doi-asserted-by': 'crossref', 'first-page': '1941', 'DOI': '10.1016/S0140-6736(22)00519-0', 'article-title': 'Remdesivir and three other drugs for hospitalised patients with ' 'COVID-19: final results of the WHO Solidarity randomised trial and ' 'updated meta-analyses', 'volume': '399', 'year': '2022', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib5', 'doi-asserted-by': 'crossref', 'first-page': '1569', 'DOI': '10.1016/S0140-6736(20)31022-9', 'article-title': 'Remdesivir in adults with severe COVID-19: a randomised, double-blind, ' 'placebo-controlled, multicentre trial', 'volume': '395', 'author': 'Wang', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib6', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/ofid/ofad482', 'article-title': 'Remdesivir is associated with reduced mortality in COVID-19 patients ' 'requiring supplemental oxygen including invasive mechanical ventilation ' 'across SARS-CoV-2 variants', 'volume': '10', 'author': 'Mozaffari', 'year': '2023', 'journal-title': 'Open Forum Infect Dis'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib7', 'article-title': 'Infectious Diseases Society of America guidelines on the treatment and ' 'management of patients with coronavirus disease 2019 (COVID-19)', 'author': 'Bhimraj', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib8', 'series-title': 'Coronavirus disease 2019 (COVID-19) treatment guidelines', 'year': '2021'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib9', 'article-title': 'A living WHO guideline on drugs for COVID-19', 'volume': '370', 'author': 'Agarwal', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib10', 'doi-asserted-by': 'crossref', 'first-page': '1397', 'DOI': '10.1056/NEJMoa2118542', 'article-title': 'Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19', 'volume': '386', 'author': 'Hammond', 'year': '2022', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib11', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/v15071577', 'article-title': 'Synergistic activity of remdesivir–nirmatrelvir combination on a ' 'SARS-CoV-2 in vitro model and a case report', 'volume': '15', 'author': 'Gidari', 'year': '2023', 'journal-title': 'Viruses'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib12', 'doi-asserted-by': 'crossref', 'first-page': '301', 'DOI': '10.1186/s12985-023-02269-8', 'article-title': 'Optimizing COVID-19 treatment in immunocompromised patients: early ' 'combination therapy with remdesivir, nirmatrelvir/ritonavir and ' 'sotrovimab', 'volume': '20', 'author': 'Gentile', 'year': '2023', 'journal-title': 'Virol J'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib13', 'doi-asserted-by': 'crossref', 'first-page': '280', 'DOI': '10.1093/cid/ciad181', 'article-title': 'Triple combination therapy with 2 antivirals and monoclonal antibodies ' 'for persistent or relapsed severe acute respiratory syndrome ' 'coronavirus 2 infection in immunocompromised patients', 'volume': '77', 'author': 'Mikulska', 'year': '2023', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib14', 'doi-asserted-by': 'crossref', 'first-page': '904', 'DOI': '10.1002/hon.3206', 'article-title': 'Dual combined antiviral treatment with remdesivir and ' 'nirmatrelvir/ritonavir in patients with impaired humoral immunity and ' 'persistent SARS-CoV-2 infection', 'volume': '41', 'author': 'Pasquini', 'year': '2023', 'journal-title': 'Hematol Oncol'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib16', 'doi-asserted-by': 'crossref', 'first-page': '138', 'DOI': '10.1186/1472-6963-8-138', 'article-title': 'Health services research in the public healthcare system in Hong Kong: ' 'an analysis of over 1 million antihypertensive prescriptions between ' '2004–2007 as an example of the potential and pitfalls of using ' 'routinely collected electronic patient data', 'volume': '8', 'author': 'Wong', 'year': '2008', 'journal-title': 'BMC Health Serv Res'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib17', 'article-title': 'Cardiovascular outcomes associated with use of clarithromycin: ' 'population based study', 'volume': '352', 'author': 'Wong', 'year': '2016', 'journal-title': 'BMJ'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib18', 'doi-asserted-by': 'crossref', 'first-page': '64', 'DOI': '10.1016/S1473-3099(21)00451-5', 'article-title': "Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated " '(CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control ' 'study', 'volume': '22', 'author': 'Wan', 'year': '2022', 'journal-title': 'Lancet Infect Dis'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib19', 'doi-asserted-by': 'crossref', 'first-page': '411', 'DOI': '10.1038/s41467-022-28068-3', 'article-title': 'Multimorbidity and adverse events of special interest associated with ' 'COVID-19 vaccines in Hong Kong', 'volume': '13', 'author': 'Lai', 'year': '2022', 'journal-title': 'Nat Commun'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib20', 'doi-asserted-by': 'crossref', 'first-page': '14', 'DOI': '10.1093/ckj/sfab158', 'article-title': 'An introduction to inverse probability of treatment weighting in ' 'observational research', 'volume': '15', 'author': 'Chesnaye', 'year': '2021', 'journal-title': 'Clin Kidney J'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib21', 'doi-asserted-by': 'crossref', 'first-page': 'e192', 'DOI': '10.1016/S1473-3099(20)30483-7', 'article-title': 'A minimal common outcome measure set for COVID-19 clinical research', 'volume': '20', 'author': 'Marshall', 'year': '2020', 'journal-title': 'Lancet Infect Dis'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib22', 'doi-asserted-by': 'crossref', 'first-page': '209', 'DOI': '10.1016/S1473-3099(21)00485-0', 'article-title': 'Remdesivir plus standard of care versus standard of care alone for the ' 'treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a ' 'phase 3, randomised, controlled, open-label trial', 'volume': '22', 'author': 'Ader', 'year': '2022', 'journal-title': 'Lancet Infect Dis'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib23', 'doi-asserted-by': 'crossref', 'first-page': '696', 'DOI': '10.1016/S1473-3099(23)00011-7', 'article-title': 'Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 ' 'during the era of omicron variants including BA.4 and BA.5 in Colorado, ' 'USA: a retrospective cohort study', 'volume': '23', 'author': 'Aggarwal', 'year': '2023', 'journal-title': 'Lancet Infect Dis'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib24', 'doi-asserted-by': 'crossref', 'first-page': '268', 'DOI': '10.7326/M16-2607', 'article-title': 'Sensitivity analysis in observational research: introducing the E-value', 'volume': '167', 'author': 'VanderWeele', 'year': '2017', 'journal-title': 'Ann Intern Med'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib25', 'article-title': 'Remdesivir for the treatment of COVID-19', 'volume': '1', 'author': 'Grundeis', 'year': '2023', 'journal-title': 'Cochrane Database Syst Rev'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib26', 'doi-asserted-by': 'crossref', 'first-page': '507', 'DOI': '10.1080/22221751.2021.1898291', 'article-title': 'Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 ' 'pandemic', 'volume': '10', 'author': 'To', 'year': '2021', 'journal-title': 'Emerg Microbes Infect'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib27', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/ijms241914973', 'article-title': 'Changes in lymphocyte subpopulations after remdesivir therapy for ' 'COVID-19: a brief report', 'volume': '24', 'author': 'Cianci', 'year': '2023', 'journal-title': 'Int J Mol Sci'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib28', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/AAC.00602-21', 'article-title': 'Key metabolic enzymes involved in remdesivir activation in human lung ' 'cells', 'volume': '65', 'author': 'Li', 'year': '2021', 'journal-title': 'Antimicrob Agents Chemother'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib29', 'doi-asserted-by': 'crossref', 'first-page': '3595', 'DOI': '10.4049/jimmunol.1600055', 'article-title': 'HIV protease inhibitor-induced cathepsin modulation alters antigen ' 'processing and cross-presentation', 'volume': '196', 'author': 'Kourjian', 'year': '2016', 'journal-title': 'J Immunol'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib30', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2022.105430', 'article-title': 'Combination therapy with nirmatrelvir and molnupiravir improves the ' 'survival of SARS-CoV-2 infected mice', 'volume': '208', 'author': 'Jeong', 'year': '2022', 'journal-title': 'Antiviral Res'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib31', 'doi-asserted-by': 'crossref', 'first-page': '154', 'DOI': '10.1038/s42003-022-03101-9', 'article-title': 'Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and ' 'exonuclease and demonstrates COVID-19 therapeutic potential in viral ' 'cell culture', 'volume': '5', 'author': 'Wang', 'year': '2022', 'journal-title': 'Commun Biol'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib32', 'first-page': '1', 'article-title': 'Efficacy and safety of Paxlovid in severe adult patients with ' 'SARS-Cov-2 infection: a multicenter randomised controlled study', 'volume': '33', 'author': 'Liu', 'year': '2023', 'journal-title': 'Lancet Reg Health West Pac'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib33', 'doi-asserted-by': 'crossref', 'first-page': '1406', 'DOI': '10.1093/cid/ciad371', 'article-title': 'Safety profile and clinical and virological outcomes of ' 'nirmatrelvir–ritonavir treatment in patients with advanced chronic ' 'kidney disease and coronavirus disease 2019', 'volume': '77', 'author': 'Chan', 'year': '2023', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib34', 'doi-asserted-by': 'crossref', 'first-page': '1191', 'DOI': '10.1002/cpt.2646', 'article-title': 'Recommendations for the management of drug–drug interactions between ' 'the COVID-19 antiviral nirmatrelvir/ritonavir (Paxlovid) and ' 'comedications', 'volume': '112', 'author': 'Marzolini', 'year': '2022', 'journal-title': 'Clin Pharmacol Ther'}, { 'key': '10.1016/S1473-3099(24)00353-0_bib35', 'article-title': 'A practical guide to handling competing events in etiologic ' 'time-to-event studies', 'volume': '4', 'author': 'Mansournia', 'year': '2022', 'journal-title': 'Glob Epidemiol'}], 'container-title': 'The Lancet Infectious Diseases', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1473309924003530?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1473309924003530?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2024, 7, 15]], 'date-time': '2024-07-15T22:33:13Z', 'timestamp': 1721082793000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1473309924003530'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 7]]}, 'references-count': 33, 'alternative-id': ['S1473309924003530'], 'URL': 'http://dx.doi.org/10.1016/S1473-3099(24)00353-0', 'relation': {}, 'ISSN': ['1473-3099'], 'subject': [], 'container-title-short': 'The Lancet Infectious Diseases', 'published': {'date-parts': [[2024, 7]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir ' 'and remdesivir versus monotherapy with remdesivir or nirmatrelvir–ritonavir in ' 'patients hospitalised with COVID-19: a target trial emulation study', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'The Lancet Infectious Diseases', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/S1473-3099(24)00353-0', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, { 'value': 'https://doi.org/10.1016/S1473-3099(24)00407-9', 'name': 'associatedlink', 'label': 'CrossRef DOI link to the associated document'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2024 Elsevier Ltd. All rights are reserved, including those for text and data ' 'mining, AI training, and similar technologies.', 'name': 'copyright', 'label': 'Copyright'}]}